Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -241.64% | 126.31% | -508.45% | 11.43% | 28.98% |
| Total Depreciation and Amortization | 0.39% | 6.22% | 2.99% | 1.74% | 1.77% |
| Total Amortization of Deferred Charges | 18.17% | 20.28% | 137.34% | -29.94% | -9.71% |
| Total Other Non-Cash Items | 107.52% | -175.10% | 1,928.66% | -14.11% | -23.15% |
| Change in Net Operating Assets | 1,292.31% | 108.32% | -109.38% | -127.28% | 19.59% |
| Cash from Operations | 13.04% | 28.79% | -127.27% | -1,032.98% | 120.41% |
| Capital Expenditure | -- | 100.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -- | -- | -75.59% | 3,500.00% |
| Cash from Investing | 100.00% | 4.21% | -414.46% | -75.59% | 3,500.00% |
| Total Debt Issued | -45.07% | -8.61% | 69.79% | 157.29% | -32.62% |
| Total Debt Repaid | 22.82% | 11.83% | -25.95% | 28.42% | -83.60% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -53.70% | -7.32% | 97.92% | 488.70% | -156.13% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -215.80% | 388.50% | -162.09% | -- | -- |